Regusol 5 mg Tablet

Manufactured byALEMBIC LTD
ContainsSolifenacin
OFFER
Get 25% OFF!
Valid on prescription medicines, only for first time user
PRACTO
PRACTO
COPY CODE
Description

Regusol 5 mg Tablet is used for the treatment of an overactive bladder, a condition characterized by symptoms such as a frequent feeling of a need to urinate, sudden urge to urinate, inability to control urination, leaking of urine, etc. This medicine is not recommended for use in patients less than 18 years of age.

Substitutes

List of substitutes for Regusol 5 mg Tablet

Soliten 5 Tablet
Sun Pharma Laboratories Ltd.

Side effects

Major & minor side effects for Regusol 5 mg Tablet

  • Dry mouth
  • Constipation
  • Nausea and vomiting
  • Abdominal pain
  • Cough
  • Nasal dryness
  • Blurred vision
  • Dry skin
  • Headache
  • Dizziness
  • Extreme tiredness
  • Back pain

Uses of Regusol 5 mg Tablet

What is it prescribed for?

  • Overactive Bladder
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time required for this medicine to show its action is not clinically established.
  • Duration of effect
    The effect of this medicine lasts for an average duration of 24 hours.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit forming tendency has been reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If this medicine is used, close monitoring of the infant for any undesired side effects is recommended.

Allergy

This medicine is not recommended for use in patients with a known allergy to solifenacin or any other inactive ingredients present along with this medicine.

Severe liver impairment

This medicine is not recommended for use in patients suffering from severe liver function impairment due to the increased risk of serious adverse effects.

Urinary retention

This medicine is not recommended for use in patients suffering from urinary retention, a condition where the patient is unable to empty the bladder, due to the increased risk of worsening of the patient's condition.

Narrow angle glaucoma

This medicine is not recommended for use in patients suffering from an uncontrolled narrow-angle glaucoma due to the increased risk of worsening of the patient's condition.

Gastric retention

This medicine is not recommended for use in patients suffering from gastric retention due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If this medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings

Angioedema and anaphylactic reactions

This medicine may cause angioedema (swelling) of the face, lips, tongue, etc. as well as severe allergic reactions in some patients. Seek immediate medical intervention if any such reactions develop. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Central nervous system side effects

This medicine may cause central nervous system side effects such as a headache, confusion, hallucinations, sleepiness in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any such symptoms during treatment with this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Pediatric population

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Driving or operating machines

Use of this medicine may cause symptoms such as dizziness, drowsiness, blurred vision, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

If a dose of this medicine is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose. Do not double the dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Clotrimazole

Itraconazole

Clozapine

Amiodarone

Fluoroquinolones

Disease interactions

Renal impairment

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of renal function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Liver impairment

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Central nervous system disorders

This medicine should be used with caution in patients suffering from central nervous system disorders such as Parkinson's disease, preexisting dementia, etc. due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

QT Prolongation

This medicine should be used with caution in patients with a known history of QT prolongation or patients receiving medications known to prolong QT interval due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine exactly as instructed by the doctor. Do not take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine relaxes the urinary bladder muscles; this helps the bladder to retain a larger amount of urine and prevents the symptoms of an overactive bladder.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Urinary antispasmodics

Schedule

Schedule H

DailyMed - Solifenacin succinate tablet, film coated [Internet]. Dailymed.nlm.nih.gov. 2018 [cited 26 July 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9acee910-cdb2-4052-b8b3-c26aff1c8716

Solifenacin - DrugBank [Internet]. Drugbank.ca. 2018 [cited 26 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB01591

[Internet]. Astellas.us. 2018 [cited 26 July 2018]. Available from:

https://www.astellas.us/docs/vesicare.pdf

[Internet]. Medsafe.govt.nz. 2018 [cited 26 July 2018]. Available from:

http://www.medsafe.govt.nz/profs/Datasheet/v/Vesicaretab.pdf

Solifenacin: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 26 July 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a605019.html

Vesicare 5mg film-coated tablets - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 26 July 2018]. Available from:

https://www.medicines.org.uk/emc/product/5559/
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Book a doctor

Chat with verified doctors starting @ ₹99
Book now
Something doesn’t feel right?
Report an error